These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 11509012)

  • 1. Prediction of Sanfilippo phenotype severity from immunoquantification of heparan-N-sulfamidase in cultured fibroblasts from mucopolysaccharidosis type IIIA patients.
    Perkins KJ; Muller V; Weber B; Hopwood JJ
    Mol Genet Metab; 2001 Aug; 73(4):306-12. PubMed ID: 11509012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
    Yogalingam G; Hopwood JJ
    Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations.
    Valstar MJ; Neijs S; Bruggenwirth HT; Olmer R; Ruijter GJ; Wevers RA; van Diggelen OP; Poorthuis BJ; Halley DJ; Wijburg FA
    Ann Neurol; 2010 Dec; 68(6):876-87. PubMed ID: 21061399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome).
    Meyer A; Kossow K; Gal A; Steglich C; Mühlhausen C; Ullrich K; Braulke T; Muschol N
    Hum Mutat; 2008 May; 29(5):770. PubMed ID: 18407553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome.
    Scott HS; Blanch L; Guo XH; Freeman C; Orsborn A; Baker E; Sutherland GR; Morris CP; Hopwood JJ
    Nat Genet; 1995 Dec; 11(4):465-7. PubMed ID: 7493035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of recombinant murine sulfamidase.
    Gliddon BL; Yogalingam G; Hopwood JJ
    Mol Genet Metab; 2004 Nov; 83(3):239-45. PubMed ID: 15542395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.
    Emre S; Terzioglu M; Tokatli A; Coskun T; Ozalp I; Weber B; Hopwood JJ
    Hum Mutat; 2002 Feb; 19(2):184-5. PubMed ID: 11793481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport, enzymatic activity, and stability of mutant sulfamidase (SGSH) identified in patients with mucopolysaccharidosis type III A.
    Muschol N; Storch S; Ballhausen D; Beesley C; Westermann JC; Gal A; Ullrich K; Hopwood JJ; Winchester B; Braulke T
    Hum Mutat; 2004 Jun; 23(6):559-66. PubMed ID: 15146460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A).
    Bunge S; Ince H; Steglich C; Kleijer WJ; Beck M; Zaremba J; van Diggelen OP; Weber B; Hopwood JJ; Gal A
    Hum Mutat; 1997; 10(6):479-85. PubMed ID: 9401012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and functional characterization of human mutant sulfamidase in insect cells.
    Montfort M; Garrido E; Hopwood JJ; Grinberg D; Chabás A; Vilageliu L
    Mol Genet Metab; 2004 Nov; 83(3):246-51. PubMed ID: 15542396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the HGSNAT gene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C syndrome). Mutation in brief #959. Online.
    Fedele AO; Filocamo M; Di Rocco M; Sersale G; Lübke T; di Natale P; Cosma MP; Ballabio A
    Hum Mutat; 2007 May; 28(5):523. PubMed ID: 17397050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic stem cell-derived glial precursors as a vehicle for sulfamidase production in the MPS-IIIA mouse brain.
    Robinson AJ; Zhao G; Rathjen J; Rathjen PD; Hutchinson RG; Eyre HJ; Hemsley KM; Hopwood JJ
    Cell Transplant; 2010; 19(8):985-98. PubMed ID: 20350350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of phenotypic severity in mucopolysaccharidosis type IIIA.
    Knottnerus SJG; Nijmeijer SCM; IJlst L; Te Brinke H; van Vlies N; Wijburg FA
    Ann Neurol; 2017 Nov; 82(5):686-696. PubMed ID: 29023963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome.
    Muschol N; Pohl S; Meyer A; Gal A; Ullrich K; Braulke T
    Am J Med Genet A; 2011 Jul; 155A(7):1634-9. PubMed ID: 21671382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a mutation causing mucopolysaccharidosis type IIIA in New Zealand Huntaway dogs.
    Yogalingam G; Pollard T; Gliddon B; Jolly RD; Hopwood JJ
    Genomics; 2002 Feb; 79(2):150-3. PubMed ID: 11829484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of neuropathology in mucopolysaccharidosis I patients.
    Fuller M; Brooks DA; Evangelista M; Hein LK; Hopwood JJ; Meikle PJ
    Mol Genet Metab; 2005 Jan; 84(1):18-24. PubMed ID: 15639191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene.
    Jansen AC; Cao H; Kaplan P; Silver K; Leonard G; De Meirleir L; Lissens W; Liebaers I; Veilleux M; Andermann F; Hegele RA; Andermann E
    Arch Neurol; 2007 Nov; 64(11):1629-34. PubMed ID: 17998446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA.
    King B; Savas P; Fuller M; Hopwood J; Hemsley K
    Mol Genet Metab; 2006 Feb; 87(2):107-12. PubMed ID: 16352454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral injection of sulfamidase delays neuropathology in murine MPS-IIIA.
    Savas PS; Hemsley KM; Hopwood JJ
    Mol Genet Metab; 2004 Aug; 82(4):273-85. PubMed ID: 15308125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.